Found: 159
Select item for more details and to access through your institution.
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [<sup>111</sup>In]In‐XYIMSR‐01 for phase I regulatory approval.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2021, v. 64, n. 6, p. 243, doi. 10.1002/jlcr.3906
- By:
- Publication type:
- Article
Girth‐based administered activity for pediatric <sup>99m</sup>Tc‐DMSA SPECT.
- Published in:
- Medical Physics, 2024, v. 51, n. 2, p. 1019, doi. 10.1002/mp.16602
- By:
- Publication type:
- Article
A persistent belief in radiopharmaceutical therapy.
- Published in:
- Medical Physics, 2023, v. 50, p. 104, doi. 10.1002/mp.16272
- By:
- Publication type:
- Article
Current pediatric administered activity guidelines for <sup>99m</sup>Tc‐DMSA SPECT based on patient weight do not provide the same task‐based image quality.
- Published in:
- Medical Physics, 2019, v. 46, n. 11, p. 4847, doi. 10.1002/mp.13787
- By:
- Publication type:
- Article
Depth-dependent concentrations of hematopoietic stem cells in the adult skeleton: Implications for active marrow dosimetry.
- Published in:
- Medical Physics, 2017, v. 44, n. 2, p. 747, doi. 10.1002/mp.12056
- By:
- Publication type:
- Article
Quantitative impact of changes in marrow cellularity, skeletal size, and bone mineral density on active marrow dosimetry based upon a reference model.
- Published in:
- Medical Physics, 2017, v. 44, n. 1, p. 272, doi. 10.1002/mp.12002
- By:
- Publication type:
- Article
Development and evaluation of convergent and accelerated penalized SPECT image reconstruction methods for improved dose-volume histogram estimation in radiopharmaceutical therapy.
- Published in:
- Medical Physics, 2014, v. 41, n. 11, p. 1, doi. 10.1118/1.4897613
- By:
- Publication type:
- Article
Three-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy.
- Published in:
- Medical Physics, 2012, v. 39, n. 10, p. 6118, doi. 10.1118/1.4752213
- By:
- Publication type:
- Article
A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy.
- Published in:
- Medical Physics, 2011, v. 38, n. 6, p. 2892, doi. 10.1118/1.3576051
- By:
- Publication type:
- Article
Real-time quantitation of thyroidal radioiodine uptake in thyroid disease with monitoring by a collar detection device.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97408-y
- By:
- Publication type:
- Article
Basal Cell Carcinoma Within a Nevus Flammeus. Report of a Case.
- Published in:
- 1991
- By:
- Publication type:
- Report
Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCs.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Therapeutic efficacy and dose-limiting toxicity of auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: Evaluation of.
- Published in:
- International Journal of Cancer, 1998, v. 76, n. 5, p. 738, doi. 10.1002/(SICI)1097-0215(19980529)76:5<738::AID-IJC20>3.0.CO;2-Z
- By:
- Publication type:
- Article
Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.
- Published in:
- Nature Medicine, 2008, v. 14, n. 10, p. 1118, doi. 10.1038/nm.1864
- By:
- Publication type:
- Article
HUMAN BRAIN DOSIMETRY IN DISRUPTED BLOOD BRAIN BARRIER (BBB) USING [SN-117M]-DOTA-ANNEXIN V (SNDAV): A MODEL FOR TARGETING AGED MICROGLIA IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1021, doi. 10.1016/j.jalz.2016.06.2106
- By:
- Publication type:
- Article
Biological Analysis and Dosimetry for <sup>15</sup>O-Labeled O<sub>2</sub>, CO<sub>2</sub>, and CO Gases Administered Continuously by Inhalation.
- Published in:
- Journal of Nuclear Medicine, 1983, v. 24, n. 5, p. 431
- By:
- Publication type:
- Article
Trafficking of High Avidity HER-2/neu-Specific T Cells into HER-2/neu-Expressing Tumors after Depletion of Effector/Memory-Like Regulatory T Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031962
- By:
- Publication type:
- Article
Prognostic Value of [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid Cancer.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 3, p. 1107, doi. 10.1210/jcem.85.3.6458
- By:
- Publication type:
- Article
Improved accuracy of S-value-based dosimetry: a guide to transition from Cristy–Eckerman to ICRP adult phantoms.
- Published in:
- EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00485-9
- By:
- Publication type:
- Article
Dosimetric impact of Ac-227 in accelerator-produced Ac-225 for alpha-emitter radiopharmaceutical therapy of patients with hematological malignancies: a pharmacokinetic modeling analysis.
- Published in:
- EJNMMI Physics, 2021, v. 8, n. 1, p. 1, doi. 10.1186/s40658-021-00410-6
- By:
- Publication type:
- Article
Renal 99mTc-DMSA pharmacokinetics in pediatric patients.
- Published in:
- EJNMMI Physics, 2021, v. 8, n. 1, p. 1, doi. 10.1186/s40658-021-00401-7
- By:
- Publication type:
- Article
Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (111 In)/Yttrium 90 (90 Y) Ibritumomab Tiuxetan (Zevalin ®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2828, doi. 10.3390/cancers13112828
- By:
- Publication type:
- Article
Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates.
- Published in:
- Cancer (0008543X), 1997, v. 80, n. S12, p. 2591, doi. 10.1002/(SICI)1097-0142(19971215)80:12+<2591::AID-CNCR35>3.0.CO;2-5
- By:
- Publication type:
- Article
Single chain antigen binding protein (sFv CC49).
- Published in:
- Cancer (0008543X), 1997, v. 80, n. S12, p. 2458, doi. 10.1002/(SICI)1097-0142(19971215)80:12+<2458::AID-CNCR17>3.0.CO;2-B
- By:
- Publication type:
- Article
Indoor air quality assessment in the air traffic control tower of the Athens Airport, Greece.
- Published in:
- Environmental Monitoring & Assessment, 2009, v. 148, n. 1-4, p. 47, doi. 10.1007/s10661-007-0138-9
- By:
- Publication type:
- Article
Alpha Particle Emitter Radiolabeled Antibody for Metastatic Cancer: What Can We Learn from Heavy Ion Beam Radiobiology?
- Published in:
- Antibodies (2073-4468), 2012, v. 1, n. 2, p. 124, doi. 10.3390/antib1020124
- By:
- Publication type:
- Article
Accuracy in dosimetry of diagnostic agents: impact of the number of source tissues used in whole organ S value-based calculations.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-0614-6
- By:
- Publication type:
- Article
Rationales, evidence, and design considerations for fractionated radioimmunotherapy.
- Published in:
- Cancer (0008543X), 2002, v. 94, n. S4, p. 1332, doi. 10.1002/cncr.10304
- By:
- Publication type:
- Article
Three-dimensional radiobiological dosimetry (3D-RD) with I PET for I therapy of thyroid cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, p. 41, doi. 10.1007/s00259-011-1769-1
- By:
- Publication type:
- Article
Pre-therapeutic <sup>124</sup>I PET(/CT) dosimetry confirms low average absorbed doses per administered <sup>131</sup>I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 5, p. 884, doi. 10.1007/s00259-009-1351-2
- By:
- Publication type:
- Article
Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model.
- Published in:
- EJNMMI Research, 2017, v. 7, n. 1, p. 1, doi. 10.1186/s13550-017-0303-2
- By:
- Publication type:
- Article
Binding and interstitial penetration of liposomes within avascular tumor spheroids.
- Published in:
- International Journal of Cancer, 2004, v. 112, n. 4, p. 713, doi. 10.1002/ijc.20457
- By:
- Publication type:
- Article
Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies.
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 6, p. 985, doi. 10.1002/(SICI)1097-0215(19990611)81:6<985::AID-IJC23>3.0.CO;2-W
- By:
- Publication type:
- Article
Phase 2 Study of Iodine-131 Tositumomab Plus Chemotherapy in Patients With Previously Untreated Mantle-Cell Lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cure of Micrometastatic B-Cell Lymphoma in a SCID Mouse Model Using <sup>213</sup>Bi-Anti-CD20 Monoclonal Antibody.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 1, p. 109, doi. 10.2967/jnumed.122.263962
- By:
- Publication type:
- Article
Cure of Micrometastatic B-cell Lymphoma in a scid Mouse Model using 213Bi AntiCD20 Monoclonal Antibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.263962
- By:
- Publication type:
- Article
Reply LTE, Single Time Point Tumor Dosimetry Assuming Normal Distribution of tumor kinetics.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263717
- By:
- Publication type:
- Article
Cure of Micrometastatic B-cell Lymphoma in a scid Mouse Model using <sup>213</sup>Bi Anti- CD20 Monoclonal Antibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.263962
- By:
- Publication type:
- Article
Reply LTE, Single Time Point Tumor Dosimetry Assuming Normal Distribution of tumor kinetics.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263717
- By:
- Publication type:
- Article
Reply LTE, Single Time Point Tumor Dosimetry Assuming Normal Distribution of tumor kinetics.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263717
- By:
- Publication type:
- Article
Reply LTE, Single Time Point Tumor Dosimetry Assuming Normal Distribution of tumor kinetics.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263717
- By:
- Publication type:
- Article
Reply LTE, Single Time Point Tumor Dosimetry Assuming Normal Distribution of tumor kinetics.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263717
- By:
- Publication type:
- Article
Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, p. 23S, doi. 10.2967/jnumed.121.262751
- By:
- Publication type:
- Article
Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, p. 3S, doi. 10.2967/jnumed.121.262749
- By:
- Publication type:
- Article
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, p. 12S, doi. 10.2967/jnumed.121.262750
- By:
- Publication type:
- Article
Combination of carriers, with complementary intratumoral microdistributions of delivered αparticles, may realize the promise for Actinium-225 in large solid tumors.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262992
- By:
- Publication type:
- Article
An improved 211At-labeled agent for PSMA-targeted alpha therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262098
- By:
- Publication type:
- Article
An improved <sup>211</sup>At-labeled agent for PSMA-targeted alpha therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262098
- By:
- Publication type:
- Article
An improved <sup>211</sup>At-labeled agent for PSMA-targeted alpha therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262098
- By:
- Publication type:
- Article